These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1521134)

  • 1. Catatonia and creatinine phosphokinase.
    Domken MA; Farquharson RG
    Br J Psychiatry; 1992 Aug; 161():283-4. PubMed ID: 1521134
    [No Abstract]   [Full Text] [Related]  

  • 2. Catatonia in the DSM--shall we move or not?
    Heckers S; Tandon R; Bustillo J
    Schizophr Bull; 2010 Mar; 36(2):205-7. PubMed ID: 19933711
    [No Abstract]   [Full Text] [Related]  

  • 3. Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients.
    Northoff G; Wenke J; Pflug B
    Psychol Med; 1996 May; 26(3):547-53. PubMed ID: 8733213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Catatonia, malignant neuroleptic syndrome and myositis ossificans].
    Topka H; Buchkremer G
    Nervenarzt; 1996 May; 67(5):413-7. PubMed ID: 9005354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does electroconvulsive therapy exacerbate the elevation of creatinine phosphokinase caused by neuroleptics.
    Geizer M; Ancill R
    Can J Psychiatry; 1996 Mar; 41(2):131. PubMed ID: 8705961
    [No Abstract]   [Full Text] [Related]  

  • 6. The myth of elevated serum creatine phosphokinase level and neuroleptic malignant syndrome.
    Adityanjee
    Br J Psychiatry; 1991 May; 158():706-7. PubMed ID: 1677602
    [No Abstract]   [Full Text] [Related]  

  • 7. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
    Ladds B; Thomas P; Mejia C; Hauser D
    Am J Psychiatry; 2009 Jan; 166(1):114-5. PubMed ID: 19122020
    [No Abstract]   [Full Text] [Related]  

  • 8. [Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review].
    Asztalos Z; Egervári L; Andrássy G; Faludi G; Frecska E
    Neuropsychopharmacol Hung; 2014 Mar; 16(1):19-28. PubMed ID: 24687015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychogenic catatonia with elevated creatine kinase and autonomic hyperactivity.
    Chandler JD
    Can J Psychiatry; 1991 Sep; 36(7):530-2. PubMed ID: 1933765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CPK levels and neuroleptic malignant syndrome.
    James S
    Br J Psychiatry; 1989 Oct; 155():567. PubMed ID: 2611586
    [No Abstract]   [Full Text] [Related]  

  • 11. CPK in NMS.
    Craddock B; Craddock N; Milner G
    Br J Psychiatry; 1991 Jan; 158():130. PubMed ID: 2015437
    [No Abstract]   [Full Text] [Related]  

  • 12. Catatonia and NMS.
    Shah AK
    Br J Psychiatry; 1991 Jul; 159():165. PubMed ID: 1888973
    [No Abstract]   [Full Text] [Related]  

  • 13. ['Catatonic dilemma'. Comments on the article by H. Lausberg and R.Hellweg. Nervenarzt (1998) 69:818-822].
    Northoff G
    Nervenarzt; 1999 May; 70(5):484-5. PubMed ID: 10407847
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome and lethal catatonia.
    Munoz RA
    Am J Psychiatry; 1987 Oct; 144(10):1369-70. PubMed ID: 2889379
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
    Schulte-Sasse U; Komar K; Eberlein HJ
    Dtsch Med Wochenschr; 1985 Mar; 110(12):457-61. PubMed ID: 3979279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic difficulties in acute viral encephalitis associated with mental disorders (a case of acute catatonia in herpes simplex encephalitis)].
    Zakrzewska B; Rowińska-Marcińska K; Kwieciński H; Guzek A; Strzelecki R; Przyjałkowski W; Lipowski D
    Neurol Neurochir Pol; 1989; 23(4-6):363-7. PubMed ID: 2637968
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine elevation of serum creatine kinase.
    Martí-Bonmatí E; San Valero-Carcelén E; Ortega-García MP; Rubini-Puig R
    J Clin Psychiatry; 2003 Apr; 64(4):483-4. PubMed ID: 12716258
    [No Abstract]   [Full Text] [Related]  

  • 18. CPK levels and neuroleptic malignant syndrome.
    Maharajh HD
    Br J Psychiatry; 1989 Jun; 154():885-6. PubMed ID: 2597905
    [No Abstract]   [Full Text] [Related]  

  • 19. Catatonia: harbinger of the neuroleptic malignant syndrome.
    White DA; Robins AH
    Br J Psychiatry; 1991 Mar; 158():419-21. PubMed ID: 1674666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
    Menard ML; Yagoubi F; Drici M; Lavrut T; Askenazy F
    Encephale; 2013 May; 39 Suppl 1():S29-35. PubMed ID: 23219595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.